125 related articles for article (PubMed ID: 38604018)
1. Discovery of two non-UDP-mimic inhibitors of O-GlcNAc transferase by screening a DNA-encoded library.
Balsollier C; Bijkerk S; de Smit A; van Eekelen K; Bozovičar K; Husstege D; Tomašič T; Anderluh M; Pieters RJ
Bioorg Chem; 2024 Jun; 147():107321. PubMed ID: 38604018
[TBL] [Abstract][Full Text] [Related]
2. A small molecule that inhibits OGT activity in cells.
Ortiz-Meoz RF; Jiang J; Lazarus MB; Orman M; Janetzko J; Fan C; Duveau DY; Tan ZW; Thomas CJ; Walker S
ACS Chem Biol; 2015 Jun; 10(6):1392-7. PubMed ID: 25751766
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAc Transferase: Structural Characteristics, Catalytic Mechanism and Small-Molecule Inhibitors.
Ju Kim E
Chembiochem; 2020 Nov; 21(21):3026-3035. PubMed ID: 32406185
[TBL] [Abstract][Full Text] [Related]
4. Bisubstrate UDP-peptide conjugates as human O-GlcNAc transferase inhibitors.
Borodkin VS; Schimpl M; Gundogdu M; Rafie K; Dorfmueller HC; Robinson DA; van Aalten DM
Biochem J; 2014 Feb; 457(3):497-502. PubMed ID: 24256146
[TBL] [Abstract][Full Text] [Related]
5. Bisubstrate Ether-Linked Uridine-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Makwana V; Ryan P; Malde AK; Anoopkumar-Dukie S; Rudrawar S
ChemMedChem; 2021 Feb; 16(3):477-483. PubMed ID: 32991074
[TBL] [Abstract][Full Text] [Related]
6. Thio-Linked UDP-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Rafie K; Gorelik A; Trapannone R; Borodkin VS; van Aalten DMF
Bioconjug Chem; 2018 Jun; 29(6):1834-1840. PubMed ID: 29723473
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors.
Martin SES; Tan ZW; Itkonen HM; Duveau DY; Paulo JA; Janetzko J; Boutz PL; Törk L; Moss FA; Thomas CJ; Gygi SP; Lazarus MB; Walker S
J Am Chem Soc; 2018 Oct; 140(42):13542-13545. PubMed ID: 30285435
[TBL] [Abstract][Full Text] [Related]
8. Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors.
Kim EJ; Abramowitz LK; Bond MR; Love DC; Kang DW; Leucke HF; Kang DW; Ahn JS; Hanover JA
Bioconjug Chem; 2014 Jun; 25(6):1025-30. PubMed ID: 24866374
[TBL] [Abstract][Full Text] [Related]
9. Substrate and product analogues as human O-GlcNAc transferase inhibitors.
Dorfmueller HC; Borodkin VS; Blair DE; Pathak S; Navratilova I; van Aalten DM
Amino Acids; 2011 Mar; 40(3):781-92. PubMed ID: 20640461
[TBL] [Abstract][Full Text] [Related]
10. Antibodies and activity measurements for the detection of O-GlcNAc transferase and assay of its substrate, UDP-GlcNAc.
Lefebvre T; Drougat L; Olivier-Van Stichelen S; Michalski JC; Vercoutter-Edouart AS
Methods Mol Biol; 2013; 1022():147-59. PubMed ID: 23765660
[TBL] [Abstract][Full Text] [Related]
11. Discovery of O-GlcNAc transferase inhibitors.
Gross BJ; Kraybill BC; Walker S
J Am Chem Soc; 2005 Oct; 127(42):14588-9. PubMed ID: 16231908
[TBL] [Abstract][Full Text] [Related]
12. Uridine diphosphate release mechanism in O-N-acetylglucosamine (O-GlcNAc) transferase catalysis.
She N; Zhao Y; Hao J; Xie S; Wang C
Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):609-622. PubMed ID: 30550897
[TBL] [Abstract][Full Text] [Related]
13. Screening oxime libraries by means of mass spectrometry (MS) binding assays: Identification of new highly potent inhibitors to optimized inhibitors γ-aminobutyric acid transporter 1.
Kern F; Wanner KT
Bioorg Med Chem; 2019 Apr; 27(7):1232-1245. PubMed ID: 30777661
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAcase: Emerging Mechanism, Substrate Recognition and Small-Molecule Inhibitors.
Elbatrawy AA; Kim EJ; Nam G
ChemMedChem; 2020 Jul; 15(14):1244-1257. PubMed ID: 32496638
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R; Rafie K; van Aalten DM
Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
[TBL] [Abstract][Full Text] [Related]
16. Discovery of small molecule inhibitors of human uridine-cytidine kinase 2 by high-throughput screening.
Okesli-Armlovich A; Gupta A; Jimenez M; Auld D; Liu Q; Bassik MC; Khosla C
Bioorg Med Chem Lett; 2019 Sep; 29(18):2559-2564. PubMed ID: 31420268
[TBL] [Abstract][Full Text] [Related]
17. Revealing the conformational dynamics of UDP-GlcNAc recognition by O-GlcNAc transferase via Markov state model.
Tian J; Dong X; Wu T; Wen P; Liu X; Zhang M; An X; Shi D
Int J Biol Macromol; 2024 Jan; 256(Pt 1):128405. PubMed ID: 38016609
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening.
Loi EM; Tomašič T; Balsollier C; van Eekelen K; Weiss M; Gobec M; Alteen MG; Vocadlo DJ; Pieters RJ; Anderluh M
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335358
[No Abstract] [Full Text] [Related]
19. Design of OSMI-4 Analogs Using Scaffold Hopping: Investigating the Importance of the Uridine Mimic in the Binding of OGT Inhibitors.
Balsollier C; Tomašič T; Yasini D; Bijkerk S; Anderluh M; Pieters RJ
ChemMedChem; 2023 Apr; 18(8):e202300001. PubMed ID: 36752318
[TBL] [Abstract][Full Text] [Related]
20. Optimised chemical synthesis of 5-substituted UDP-sugars and their evaluation as glycosyltransferase inhibitors.
Tedaldi LM; Pierce M; Wagner GK
Carbohydr Res; 2012 Dec; 364():22-7. PubMed ID: 23147042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
